"Peptide Fragments" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
| Descriptor ID |
D010446
|
| MeSH Number(s) |
D12.644.541
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peptide Fragments".
Below are MeSH descriptors whose meaning is more specific than "Peptide Fragments".
This graph shows the total number of publications written about "Peptide Fragments" by people in this website by year, and whether "Peptide Fragments" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 3 | 10 |
| 1997 | 2 | 5 | 7 |
| 1998 | 9 | 7 | 16 |
| 1999 | 6 | 7 | 13 |
| 2000 | 10 | 4 | 14 |
| 2001 | 9 | 6 | 15 |
| 2002 | 12 | 17 | 29 |
| 2003 | 9 | 9 | 18 |
| 2004 | 9 | 6 | 15 |
| 2005 | 10 | 7 | 17 |
| 2006 | 4 | 7 | 11 |
| 2007 | 6 | 3 | 9 |
| 2008 | 3 | 6 | 9 |
| 2009 | 4 | 14 | 18 |
| 2010 | 3 | 12 | 15 |
| 2011 | 4 | 9 | 13 |
| 2012 | 11 | 9 | 20 |
| 2013 | 2 | 5 | 7 |
| 2014 | 4 | 4 | 8 |
| 2015 | 1 | 4 | 5 |
| 2016 | 3 | 2 | 5 |
| 2017 | 3 | 5 | 8 |
| 2018 | 3 | 3 | 6 |
| 2019 | 3 | 7 | 10 |
| 2020 | 2 | 4 | 6 |
| 2021 | 4 | 2 | 6 |
| 2022 | 0 | 6 | 6 |
| 2023 | 1 | 1 | 2 |
| 2024 | 3 | 0 | 3 |
| 2025 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peptide Fragments" by people in Profiles.
-
Poor olfaction and risk of heart failure in the Atherosclerosis Risk in Communities Study. J Gerontol A Biol Sci Med Sci. 2025 Oct 05; 80(11).
-
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia. Nat Rev Clin Oncol. 2025 Nov; 22(11):847-868.
-
Fourteen Biomarkers and Subsequent Disability in Patients with Stroke Recurrence: Results from the SPARCL Trial. Eur Neurol. 2025; 88(3-4):103-112.
-
Diagnostic MicroRNA Signatures to Support Classification of Pulmonary Hypertension. Circ Genom Precis Med. 2025 Jun; 18(3):e004862.
-
White matter hyperintensity on MRI and plasma Aß42/40 ratio additively increase the risk of cognitive impairment in hypertensive adults. Alzheimers Dement. 2024 Oct; 20(10):6810-6819.
-
Normative Values of Echocardiographic Chamber Size and Function in Older Healthy Adults: The Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging. 2024 May; 17(5):e016420.
-
Bivalirudin as a substitute for heparin in neurointervention for patients with heparin-induced thrombocytopenia. J Stroke Cerebrovasc Dis. 2024 Jun; 33(6):107310.
-
Peptide YY: A Paneth cell antimicrobial peptide that maintains Candida gut commensalism. Science. 2023 08 04; 381(6657):502-508.
-
Cytokines as prognostic biomarkers in pulmonary arterial hypertension. Eur Respir J. 2023 03; 61(3).
-
N-terminal peptide fragment constitutes core of amyloid deposition of serum amyloid A: An imaging mass spectrometry study. PLoS One. 2022; 17(10):e0275993.